Trial Profile
A trial to study the effect of nivolumab for the treatment of ovarian cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2016
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary)
- Indications Ovarian cancer
- Focus Pharmacodynamics
- 11 Aug 2016 New trial record